External validation of the MSKCC nomogram to estimate five-year overall survival after surgery for stage I-III colon cancer in a Dutch population.
Marinde J G BondPatricia A H HamersGeraldine R VinkWilhelmina M U van GrevensteinMiangela M LacléMaarten van SmedenMiriam KoopmanJeanine M L RoodhartCornelis J A PuntAnne E MayPublished in: Acta oncologica (Stockholm, Sweden) (2022)
The external validation of the MSKCC prediction nomogram in a large Dutch cohort supports the use of this practical tool in the European patient population. These personalised estimated survival probabilities may support clinicians when informing patients about prognosis. Adding potential relevant prognostic factors to the model, such as primary tumour location, might further improve the model.